Skip to main content

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

AmerisourceBergen

(ABC) - Get AmerisourceBergen Corporation Report

rated new Buy at Mizuho. $42 price target. Company is likely to retain the ESRX/MHS contract.

TD Ameritrade

(AMTD) - Get TD Ameritrade Holding Corporation Report

downgraded to hold at TheStreet Ratings.

First PacTrust Bancorp

(BANC) - Get Banc of California Incorporated Report

upgraded to buy at TheStreet Ratings.

Cardinal Health

(CAH) - Get Cardinal Health, Inc. Report

rated new Neutral at Mizuho. $45 price target. Company lacks near-term catalysts.

TheStreet Recommends

Crocs

(CROX) - Get Crocs, Inc. Report

rated new Buy at Benchmark. Valuation call, based on a $23 price target.

Cisco

(CSCO) - Get Cisco Systems, Inc. Report

rated new Hold at Think. $18 price target. Near term outlook likely to remain depressed.

Facebook

(FB) - Get Meta Platforms Inc. Class A Report

rated new Buy at Nomura. $40 price target. Company can continue to grow and take market share in the display market.

Corning

(GLW) - Get Corning Inc Report

upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. Panel pricing appears to have bottomed.

ITT Industries

(ITT) - Get ITT, Inc. Report

downgraded at FBR from Market Perform to Underperform, FBR Capital Markets said. $15.50 price target. Company is facing multiple growth headwinds.

Jack in the Box

(JACK) - Get Jack in the Box Inc. Report

upgraded at BofA Merrill to Buy from Underperform, Bank of America Merrill Lynch said. $32 price target. Better sales and more modest food cost inflation.

Key Energy

(KEG) - Get Key Energy Services, Inc. Report

downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $9 price target. Business recovery has proven more challenging than expected.

Kimberly-Clark

(KMB) - Get Kimberly-Clark Corporation Report

upgraded at Argus from Hold to Buy, Argus Research said. $92 price target. Company is a market leader and emerging markets should drive growth.

McKesson

(MCK) - Get McKesson Corporation Report

rated new Neutral at Mizuho. Valuation call, based on a $99 price target.

Onyx Pharmaceuticals

(ONXX)

upgraded at Morgan Stanley from Underweight to Equal-weight, Morgan Stanley said. Kyprolis will likely be approved by the FDA.

Universal Display

(PANL) - Get Pangaea Logistics Solutions Ltd. Report

rated new Buy at Deutsche Bank. $45 price target. Shares are undervalued and have several catalysts.

PPG Industries

(PPG) - Get PPG Industries, Inc. Report

rated new Outperform at Baird. $120 price target. Company is positioned well for an eventual domestic housing recovery.

Ryder System

(R) - Get Ryder System, Inc. Report

downgraded at Wells Fargo to Market Perform from Outperform, Wells Fargo said. $41 to $45 valuation range. Truck cycle may be slowing more than expected.

Ralph Lauren

(RL) - Get Ralph Lauren Corporation Class A Report

rated new Neutral at JP Morgan. $155 price target.

Sherwin-Williams

(SHW) - Get Sherwin-Williams Company Report

rated new Neutral at Baird. Valuation call, based on a $140 price target.

SXC Health

(SXCI)

upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $109 price target. CHSI acquisition should bolster growth.

VF Corp.

(VFC) - Get V.F. Corporation Report

rated new Overweight at JP Morgan. $167 price target. Company has a solid portfolio and management team.

STOCK COMMENTS / EPS CHANGES

Celgene

(CELG) - Get Celgene Corporation Report

numbers lowered at Jefferies. Shares of CELG now seen reaching $75, Jefferies said. Estimates also lowered on approval delay. Buy rating.

Celgene estimates, target cut at Morgan Stanley. Shares of CELG now seen reaching $75, according to Morgan Stanley. Estimates also reduced, given disappointing trial data for Revlimid. Overweight rating.

Eaton

(ETN) - Get Eaton Corp. Plc Report

target lowered at UBS to $40, UBS said. Macro uncertainty and associated EPS risk. Neutral rating.

Google

(GOOG) - Get Alphabet Inc. Class C Report

numbers lowered at Citigroup. Shares of GOOG now seen reaching $740, Citigroup said. Estimates also lowered on macro uncertainty and FX weakness. Buy rating.

Illumina

(ILMN) - Get Illumina, Inc. Report

added to Focus List at Credit Suisse. Company is a market leader with its HiSeq machines.

Merck

(MRK) - Get Merck & Co., Inc. Report

added to Focus List at Credit Suisse. Company has a solid dividend and multiple potential catalysts in its pipeline.

Ryder

(R) - Get Ryder System, Inc. Report

estimates, target reduced at Keybanc. Shares of R now seen reaching $50, according to Keybanc. Estimates also cut, given a lower commercial rental outlook. Buy rating.

Ryder System numbers lowered at Jefferies. Shares of R now seen reaching $61, Jefferies said. Estimates also lowered on lower guidance. Buy rating.

AT&T

(T) - Get AT&T Inc. Report

target raised at Oppenheimer. Shares of T now seen reaching $40, Oppenheimer said. Positive meeting with management. Outperform rating.

Valeant Pharmaceuticals

(VRX)

numbers lowered at Jefferies. Shares of VRX now seen reaching $63, Jefferies said. Estimates also lowered on a more realistic market. Buy rating.

Verizon

(VZ) - Get Verizon Communications Inc. Report

target raised at Oppenheimer to $48. Positive meeting with management. Outperform rating.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>10 Best Celebrity Homes on the Market

>>Jensen: Buy American

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.